Skip to main content
Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada flag Canada · Delayed Price · Currency is CAD
9.77
-0.10 (-1.01%)
Apr 28, 2026, 4:00 PM EST

Eupraxia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
-38.58-25.5-28.22-18.49-18.93
Upgrade
Depreciation & Amortization
0.240.170.160.150.09
Upgrade
Loss (Gain) From Sale of Assets
0-0.0200.01-
Upgrade
Stock-Based Compensation
8.763.221.411.432.71
Upgrade
Other Operating Activities
1.74-1.10.550.994.72
Upgrade
Change in Accounts Receivable
-0.43-0.1-0.10.230.15
Upgrade
Change in Accounts Payable
2.36-0.710.581.32-0.5
Upgrade
Change in Other Net Operating Assets
-2.64-5.954.88-0.040.05
Upgrade
Operating Cash Flow
-28.55-29.99-20.75-14.4-11.72
Upgrade
Capital Expenditures
-0.59-0.1-0.07-0.24-0.34
Upgrade
Sale of Property, Plant & Equipment
-0.03-0-
Upgrade
Investment in Securities
---10.07-7.11
Upgrade
Other Investing Activities
-----3.97
Upgrade
Investing Cash Flow
-0.59-0.08-0.079.83-11.42
Upgrade
Short-Term Debt Issued
----0.08
Upgrade
Long-Term Debt Issued
----10.08
Upgrade
Total Debt Issued
----10.16
Upgrade
Long-Term Debt Repaid
--9.14-0.08-0.14-0.46
Upgrade
Net Debt Issued (Repaid)
--9.14-0.08-0.149.69
Upgrade
Issuance of Common Stock
76.0654.9221.1610.9429.9
Upgrade
Financing Cash Flow
76.0645.7821.0810.839.59
Upgrade
Foreign Exchange Rate Adjustments
0.54-1.960.82-0.51-0.06
Upgrade
Net Cash Flow
47.4613.761.085.7316.39
Upgrade
Free Cash Flow
-29.14-30.1-20.82-14.63-12.06
Upgrade
Free Cash Flow Per Share
-0.73-0.89-0.86-0.76-0.97
Upgrade
Cash Interest Paid
-0.390.60.330.46
Upgrade
Levered Free Cash Flow
-16.3-20.95-10.78-8.72-12.98
Upgrade
Unlevered Free Cash Flow
-16.3-20.35-10.05-8.11-12.37
Upgrade
Change in Working Capital
-0.71-6.765.351.51-0.3
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.